20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Endothelial cells are at the interface between circulating blood and tissues. This position confers on them a crucial role in controlling oxygen and nutrient exchange and cellular trafficking between blood and the perfused organs. The endothelium adopts a structure that is specific to the needs and function of each tissue and organ and is subject to tissue-specific signalling input. In adults, endothelial cells are quiescent, meaning that they are not proliferating. Quiescence was considered to be a state in which endothelial cells are not stimulated but are instead slumbering and awaiting activating signals. However, new evidence shows that quiescent endothelium is fully awake, that it constantly receives and initiates functionally important signalling inputs and that this state is actively regulated. Signalling pathways involved in the maintenance of functionally quiescent endothelia are starting to be identified and are a combination of endocrine, autocrine, paracrine and mechanical inputs. The paracrine pathways confer a microenvironment on the endothelial cells that is specific to the perfused organs and tissues. In this Review, we present the current knowledge of organ-specific signalling pathways involved in the maintenance of endothelial quiescence and the pathologies associated with their disruption. Linking organ-specific pathways and human vascular pathologies will pave the way towards the development of innovative preventive strategies and the identification of new therapeutic targets.

          Abstract

          In this Review, Simons and colleagues present the current knowledge of organ-specific signalling pathways involved in the maintenance of endothelial quiescence and the pathologies associated with their disruption. This knowledge will assist the development of innovative preventive strategies and identification of new therapeutic targets.

          Key points

          • Quiescent endothelial cells require active maintenance to preserve normalcy in a tissue-specific manner.

          • Dysregulation of signalling pathways involved in endothelial normalcy maintenance leads to endothelial dysfunction and vascular pathologies.

          • Endothelial quiescence and normalcy are important for disease resilience.

          • Identification of organ-specific signalling pathways that maintain endothelial normalcy and quiescence will lead to new therapeutic targets supporting disease resilience and treatment of associated vascular pathologies.

          Related collections

          Most cited references205

          • Record: found
          • Abstract: found
          • Article: found

          Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

          In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The basics of epithelial-mesenchymal transition.

            The origins of the mesenchymal cells participating in tissue repair and pathological processes, notably tissue fibrosis, tumor invasiveness, and metastasis, are poorly understood. However, emerging evidence suggests that epithelial-mesenchymal transitions (EMTs) represent one important source of these cells. As we discuss here, processes similar to the EMTs associated with embryo implantation, embryogenesis, and organ development are appropriated and subverted by chronically inflamed tissues and neoplasias. The identification of the signaling pathways that lead to activation of EMT programs during these disease processes is providing new insights into the plasticity of cellular phenotypes and possible therapeutic interventions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              VEGF in Signaling and Disease: Beyond Discovery and Development

              The discovery of vascular endothelial-derived growth factor (VEGF) has revolutionized our understanding of vasculogenesis and angiogenesis during development and physiological homeostasis. Over a short span of two decades, our understanding of the molecular mechanisms by which VEGF coordinates neurovascular homeostasis has become more sophisticated. The central role of VEGF in the pathogenesis of diverse cancers and blinding eye diseases has also become evident. Elucidation of the molecular regulation of VEGF and the transformative development of multiple therapeutic pathways targeting VEGF directly or indirectly is a powerful case study of how fundamental research can guide innovation and translation. It is also an elegant example of how agnostic discovery and can transform our understanding of human disease. This review will highlight critical nodal points in VEGF biology including recent developments in immunotherapy for cancer and multi-target approaches in neovascular eye disease.
                Bookmark

                Author and article information

                Contributors
                michael.simons@yale.edu
                Journal
                Nat Rev Cardiol
                Nat Rev Cardiol
                Nature Reviews. Cardiology
                Nature Publishing Group UK (London )
                1759-5002
                1759-5010
                24 February 2021
                : 1-16
                Affiliations
                [1 ]GRID grid.47100.32, ISNI 0000000419368710, Yale Cardiovascular Research Center, Department of Internal Medicine, , Yale University School of Medicine, ; New Haven, CT USA
                [2 ]GRID grid.457348.9, Université Grenoble Alpes, INSERM, CEA, BIG-Biologie du Cancer et de l’Infection, ; Grenoble, France
                [3 ]GRID grid.414221.0, INSERM UMR_S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Hôpital Marie Lannelongue, ; Le Plessis-Robinson, France
                [4 ]GRID grid.460789.4, ISNI 0000 0004 4910 6535, Université Paris-Saclay, Faculté de Médecine, ; Le Kremlin-Bicêtre, France
                [5 ]GRID grid.47100.32, ISNI 0000000419368710, Department of Cell Biology, , Yale University School of Medicine, ; New Haven, CT USA
                Author information
                http://orcid.org/0000-0002-7572-173X
                http://orcid.org/0000-0002-8545-4452
                http://orcid.org/0000-0003-0348-7734
                Article
                517
                10.1038/s41569-021-00517-4
                7903932
                33627876
                021208fb-8204-4c68-bba5-4846ebdd257d
                © Springer Nature Limited 2021

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 18 January 2021
                Categories
                Review Article

                vascular diseases,cell biology,cardiovascular genetics

                Comments

                Comment on this article